Latest filing published 20 May 2022 for Virpax Pharmaceuticals, Inc..
Insider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Anthony P. Mack: trading record in brief
This profile gathers the share dealings of Anthony P. Mack in Virpax Pharmaceuticals, Inc., where the filings describe the role as chief executive. We count 2 filings; the first trade dates from 18 November 2021 and the latest from 18 May 2022.
Every open-market trade on record is a purchase: 2 purchases worth €185k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show 1 purchase and no sales.
The record was last updated on 20 May 2022 with an open-market purchase (€97k) in Virpax Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anthony P. Mack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,750 shares@ €1.279552.3% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-014659:0Canonical exit: 16 Aug 2022 (T+90)
- 25,125 shares@ €3.524447.7% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001521:0Canonical exit: 16 Feb 2022 (T+90)
2 of 2 declarations